MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read MoreMRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read MoreArthrosi’s investigational gout treatment is currently being evaluated in global studies
Read MoreThe two companies aim to reduce administrative burden and speed up drug delivery
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
